Angeles Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.86M Buy
7,458
+732
+11% +$742K 0.37% 35
2025
Q4
$7.23M Buy
6,726
+1,255
+23% +$1.2M 0.4% 33
2025
Q3
$4.17M Sell
5,471
-243
-4% -$181K 0.26% 41
2025
Q2
$4.45M Buy
5,714
+588
+11% +$457K 0.31% 35
2025
Q1
$4.23M Buy
5,126
+369
+8% +$307K 0.35% 36
2024
Q4
$3.67M Sell
4,757
-47
-1% -$38.9K 0.3% 36
2024
Q3
$4.26M Buy
4,804
+397
+9% +$357K 0.37% 31
2024
Q2
$3.99M Buy
4,407
+354
+9% +$283K 0.37% 31
2024
Q1
$3.15M Buy
4,053
+644
+19% +$458K 0.32% 35
2023
Q4
$1.99M Buy
3,409
+237
+7% +$138K 0.24% 39
2023
Q3
$1.7M Sell
3,172
-2,126
-40% -$1.1M 0.24% 40
2023
Q2
$2.48M Buy
5,298
+2,847
+116% +$1.19M 0.34% 29
2023
Q1
$842K Sell
2,451
-2,937
-55% -$991K 0.13% 81
2022
Q4
$1.97M Buy
5,388
+4,422
+458% +$1.57M 0.35% 39
2022
Q3
$312K Buy
966
+196
+25% +$62.1K 0.06% 120
2022
Q2
$250K Buy
770
+29
+4% +$8.71K 0.05% 145
2022
Q1
$212K Buy
+741
New +$191K 0.04% 156

Other funds holding LLY

Angeles Wealth Management's LLY Position: Q1 2026 in Review

Angeles Wealth Management increased its Eli Lilly (LLY) stake by 11% in Q1 2026, buying an estimated $742K and bringing the position to 7,458 shares worth $6.86M. The position accounts for 0.37% of the portfolio, ranked #35.

Angeles Wealth Management first reported a position in LLY in Q1 2022 and has held it in 17 quarters since. The position peaked at $7.23M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Angeles Wealth Management held 7,458 shares of Eli Lilly worth $6.86M as of Q1 2026.
  • Angeles Wealth Management bought 732 Eli Lilly shares in Q1 2026, an estimated $742K.
  • Eli Lilly made up 0.37% of Angeles Wealth Management's portfolio in Q1 2026, its #35 holding.
  • Angeles Wealth Management first reported a position in Eli Lilly in Q1 2022 and has held it in 17 quarters since.
  • Angeles Wealth Management's Eli Lilly position peaked at $7.23M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Angeles Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.